Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway
批准号:
10515772
负责人:
Nadya M Dimitrova
金额:
$35.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-06-01 至 2025-05-31
关键词:
AddressAffectArchitectureBiochemicalBiologicalBiological AssayCRISPR/Cas technologyCancer BiologyCell Cycle CheckpointChromatinChromosome MappingComplexDNADataDevelopmentDiseaseDissectionDissociationDosage Compensation (Genetics)ElementsEnhancersEpigenetic ProcessEventExposure toGADD45GGene ExpressionGenesGeneticGenetic TranscriptionGenotoxic StressGoalsGrowthImpairmentIn VitroKineticsKnowledgeMYC geneMalignant NeoplasmsMalignant neoplasm of lungMammalsMediatingMediatorModelingMolecularOncogenesOncogenicOutputPathway interactionsPhysiologicalPhysiologyPlayProcessProtein IsoformsPublishingRegulationRegulatory ElementRepressionRoleSeriesSiteStressTP53 geneTestingTherapeuticTranscriptTranscription CoactivatorTranscriptional RegulationTransformed Cell LineTranslatingTumor PromotionTumor SuppressionTumor Suppressor ProteinsUntranslated RNAWorkbiological adaptation to stressc-myc Genesexperimental studygenetic approachin vivoinnovationmouse modelnovelpreventresponsestemtooltumortumorigenesis
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
Cis-regulatory long noncoding RNAs (lncRNAs) have the unique capability to regulate the expression of
neighboring genes. Historically studied in the context of dosage compensation, there is mounting evidence that
cis-regulatory lncRNAs may also play widespread roles in normal physiology and disease development.
However, their functions and mechanisms of action have remained poorly characterized. The study proposed
herein aims to understand the role of cis-regulation in cancer biology by focusing on two lncRNAs, lncRNA-
Gadd45 and an alternative isoform of Pvt1, Pvt1b. In preliminary studies, we established that these lncRNAs
are directly regulated by the central tumor suppressor factor p53, that they act in cis to regulate their
neighboring genes, namely the tumor suppressor Gadd45 and the oncogene Myc, and that Pvt1b is involved
in suppressing clonal growth. Based on these exciting data, we have hypothesized that cis-regulatory lncRNAs
provide an unappreciated layer of regulation in the p53 network and may mediate p53-dependent stress
responses and tumor suppressive functions. To address this hypothesis, in Aim 1, we propose to perform a
comprehensive series of experiments at the cellular level, which will test whether genetic inhibition of lncRNA-
Gadd45 and Pvt1b in primary and transformed cell lines affects p53-dependent transcriptional and cellular
responses to stress. In parallel, we will examine whether genetic inhibition of the two lncRNAs in developing
tumors in a mouse model of lung cancer promotes tumor development, as shown for p53. Together, this set of
experiments will establish the physiological relevance of cis-regulatory lncRNAs in the context of the p53
network in vitro and in vivo. In Aims 2 and 3, we will elucidate the mechanism of action of lncRNA-Gadd45
and Pvt1b. Aim 2 applies an innovative genetic approach for transcript-specific degradation, developed by us,
in order to determine the functional element of cis-regulation by dissociating the accumulation of the lncRNA
transcript from the act of its transcription and from the underlying DNA elements in the locus. Findings from this
set of studies will advance the field by clarifying a controversy about the central player in local gene expression
control and may elucidate how cis-regulatory relationships become disrupted in disease states, including
cancer. Finally, in an effort to define universal principles as well as locus-specific features of cis regulation, in
Aim 3, we will determine whether cis-acting lncRNAs impact local transcriptional and epigenetic events by
examining the kinetics of transcription, the epigenetic state, and the chromatin architecture in their respective
loci. In summary, the studies proposed here take advantage of rigorous genetic approaches, elegant functional
assays, and state-of-the art molecular tools to address the contribution of cis-regulatory lncRNAs to the p53
tumor suppressor pathway. The broad significance of this work lies in its potential to expand our understanding
of the transcriptional, epigenetic, and chromatin re-organization events that take place during the physiological
response to stress and become frequently perturbed in cancer.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Long noncoding RNA amplified in lung cancer rewires cancer pathways.
肺癌中扩增的长非编码 RNA 重新连接了癌症通路。
DOI:
10.1083/jcb.202007098
发表时间:
2020
期刊:
The Journal of cell biology
影响因子:
--
作者:
[Martínez-Terroba,Elena, Dimitrova,Nadya]
通讯作者:
Dimitrova,Nadya
DOI:
10.1073/pnas.2019740118
发表时间:
2021-06-08
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Sánchez-Rivera FJ, Ryan J, Soto-Feliciano YM, Clare Beytagh M, Xuan L, Feldser DM, Hemann MT, Zamudio J, Dimitrova N, Letai A, Jacks T]
通讯作者:
Jacks T
DOI:
10.1096/fj.202001951r
发表时间:
2020-12
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[Olivero CE, Dimitrova N]
通讯作者:
Dimitrova N
Deregulation of long noncoding RNAs in cancer
-
批准号:10674961
-
项目类别:
-
资助金额:$49.57万
-
财政年份:2022
-
负责人:Nadya M Dimitrova
-
依托单位:
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway
-
批准号:10400638
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2018
-
负责人:Nadya M Dimitrova
-
依托单位:
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway
-
批准号:10153726
-
项目类别:
-
资助金额:$35.95万
-
财政年份:2018
-
负责人:Nadya M Dimitrova
-
依托单位:
Roles and mechanisms of cis-regulatory IncRNAs in the p53 tumor suppressor pathway
-
批准号:9921312
-
项目类别:
-
资助金额:$36.73万
-
财政年份:2018
-
负责人:Nadya M Dimitrova
-
依托单位:
海外基金